Pneumovax 23 (Sanofi Pasteur MSD): Clinical Trials

1 trial of Pneumovax 23 (Sanofi Pasteur MSD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Pneumovax 23 (Sanofi Pasteur MSD): new trials by email Literature Review of Pneumovax 23 (Sanofi Pasteur MSD) trials Research Report on Pneumovax 23 (Sanofi Pasteur MSD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Polysaccharide Antibody Response Study
Pneumovax 23 (Sanofi Pasteur MSD), Typhim Vi (Sanofi Pasteur MSD) - Specific Polysaccharide Antibody Deficiency
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven2002015-10-012024-07-15

Sponsors

Universitaire Ziekenhuizen KU Leuven (1)

Countries

Belgium (1)

Top investigators

Isabelle Meyts, MD, PhD (1)